Journal of Patient-Reported Outcomes (Nov 2022)

Development and validation of a disease-specific quality of life scale for adult patients with Fabry disease in Japan

  • Yuta Koto,
  • Wakana Yamashita,
  • Yoko Lee,
  • Nozomi Hadano,
  • Chikara Kokubu,
  • Norio Sakai

DOI
https://doi.org/10.1186/s41687-022-00525-z
Journal volume & issue
Vol. 6, no. 1
pp. 1 – 13

Abstract

Read online

Plain English summary Adults with Fabry disease experience severe challenges, which adversely impact their quality of life (QOL). As it is a rare disease, non-patients lack awareness of the severity of its symptoms and the resultant social difficulties of the patients. Most instruments that measure QOL are not specific enough to address issues related to Fabry disease. Therefore, in this study, a measurement instrument known as the Adult Fabry QOL (AFQOL) scale was designed and validated. The 39-item scale covers five domains that are congruent with the symptoms of adult Fabry disease. It differs from other QOL scales as it also assesses the impact of work and personal relationships on patients’ QOL and symptoms that progress in adulthood. This study has important implications for healthcare providers who treat adult patients with Fabry disease, enabling them to have a fuller picture of the unique needs of this population.

Keywords